May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

May 14, 2025

Once-Daily Pill Helps Quell Eczema in Phase 3

Overall, safety findings were consistent with those of other approved JAK1 inhibitors.

Conexiant

May 09, 2025

Psoriasis: Icotrokinra Shows Promise in Late-Stage Trial

Icotrokinra is designed to block a protein, IL-23, involved in inflammatory responses.

Reuters

May 09, 2025

Upper Face Filler Techniques Lack Standardization, Review

A new scoping review revealed significant variation in hyaluronic acid filler injection techniques for the facial upper third.

Conexiant

May 07, 2025

Dr. Vinay Prasad Shakes Up FDA Leadership

The FDA has appointed Vinay Prasad as its new vaccine chief, shaking up biotech stocks and signaling potential shifts in drug approvals.

Reuters

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

May 01, 2025

Health Care Shortage: Who’s Left Out?

“The ER then says, ‘OK, you should follow up with your primary care provider,’ and they’re like, ‘We don’t have one.’”

KFF Health News

April 28, 2025

Delgocitinib Cream Outperforms Alitretinoin in Trial

Topical delgocitinib improved eczema severity scores and caused fewer adverse events than oral alitretinoin in adults with severe chronic hand eczema, according to a phase 3 study.

Conexiant

April 28, 2025

Patients With Hidradenitis Suppurativa at Risk for Serious Infections

A new study found that 6.4% of patients with hidradenitis suppurativa were hospitalized for serious infections not related to their skin condition, with the highest risk seen in those with chronic kidney disease, anxiety, and public insurance.

Conexiant